Table of Content


Chapter 1 Methodology
1.1 Methodology
1.2 Market definitions
1.3 Forecast parameters
1.4 Data sources
1.4.1 Secondary
1.4.1.1 Paid sources
1.4.1.2 Unpaid sources
1.4.2 Primary
Chapter 2 Executive Summary
2.1 Cystic fibrosis therapeutics industry 360 degree synopsis, 2016 - 2027
2.1.1 Business trends
2.1.2 Treatment method trends
2.1.3 Distribution channel trends
2.1.4 Regional trends
Chapter 3 Cystic Fibrosis Therapeutics Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2016 - 2027
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Rise in incidence of cystic fibrosis
3.3.1.2 Advancements in therapeutics for treatment of cystic fibrosis in developed regions
3.3.1.3 Rising awareness and adoption of treatment procedures developing regions
3.3.2 Industry pitfalls and challenges
3.3.2.1 Low awareness in developing nations
3.3.2.2 High cost of surgical treatment
3.4 Growth potential analysis
3.4.1 By treatment method
3.4.2 By distribution channel
3.5 COVID-19 impact analysis
3.6 Porter’s analysis
3.7 Competitive landscape, 2020
3.7.1 Competitive matrix analysis, 2020
3.8 PESTEL analysis
Chapter 4 Cystic Fibrosis Therapeutics Market, By Treatment Method
4.1 Key segment trends
4.2 Medications
4.2.1 Market size, by region, 2016 - 2027
4.2.2 Market size, by Drug class, 2016 - 2027
4.2.2.1 CFTR modulators
4.2.2.1.1 Market size, by region, 2016 - 2027
4.2.2.2 Mucolytics
4.2.2.2.1 Market size, by region, 2016 - 2027
4.2.2.3 Bronchodilators
4.2.2.3.1 Market size, by region, 2016 - 2027
4.2.2.4 Pancreatic enzyme supplements
4.2.2.4.1 Market size, by region, 2016 - 2027
4.2.2.5 Others
4.2.2.5.1 Market size, by region, 2016 - 2027
4.2.3 Market Size, by route of administration, 2016 - 2027
4.2.3.1 Oral drugs
4.2.3.1.1 Market size, by region, 2016 - 2027
4.2.3.2 Inhaled drugs
4.2.3.2.1 Market size, by region, 2016 - 2027
4.3 Devices
4.3.1 Market size, by region, 2016 - 2027
4.4 Others
4.4.1 Market size, by region, 2016 - 2027
Chapter 5 Cystic Fibrosis Therapeutics Market, By Distribution Channel
5.1 Key segment trends
5.2 Hospitals
5.2.1 Market size, by region, 2016 - 2027
5.3 Retail pharmacies
5.3.1 Market size, by region, 2016 - 2027
5.4 Others
5.4.1 Market size, by region, 2016 - 2027
Chapter 6 Cystic Fibrosis Therapeutics Market, By Region
6.1 Key regional trends
6.2 North America
6.2.1 Market size, by country, 2016 - 2027
6.2.2 Market size, by treatment method, 2016 - 2027
6.2.2.1 Medications market size, by drug class, 2016 - 2027
6.2.2.2 Medications market size, by route of administration, 2016 - 2027
6.2.3 Market size, by distribution channel, 2016 - 2027
6.2.4 U.S.
6.2.4.1 Market size, by treatment method, 2016 - 2027
6.2.4.1.1 Medications market size, by drug class, 2016 - 2027
6.2.4.1.2 Medications market size, by route of administration, 2016 - 2027
6.2.4.2 Market size, by distribution channel, 2016 - 2027
6.2.5 Canada
6.2.5.1 Market size, by treatment method, 2016 - 2027
6.2.5.1.1 Medications market size, by drug class, 2016 - 2027
6.2.5.1.2 Medications market size, by route of administration, 2016 - 2027
6.2.5.2 Market size, by distribution channel, 2016 - 2027
6.3 Europe
6.3.1 Market size, by country, 2016 - 2027
6.3.2 Market size, by treatment method, 2016 - 2027
6.3.2.1 Medications market size, by drug class, 2016 - 2027
6.3.2.2 Medications market size, by route of administration, 2016 - 2027
6.3.3 Market size, by distribution channel, 2016 - 2027
6.3.4 Germany
6.3.4.1 Market size, by treatment method, 2016 - 2027
6.3.4.1.1 Medications market size, by drug class, 2016 - 2027
6.3.4.1.2 Medications market size, by route of administration, 2016 - 2027
6.3.4.2 Market size, by distribution channel, 2016 - 2027
6.3.5 France
6.3.5.1 Market size, by treatment method, 2016 - 2027
6.3.5.1.1 Medications market size, by drug class, 2016 - 2027
6.3.5.1.2 Medications market size, by route of administration, 2016 - 2027
6.3.5.2 Market size, by distribution channel, 2016 - 2027
6.3.6 UK
6.3.6.1 Market size, by treatment method, 2016 - 2027
6.3.6.1.1 Medications market size, by drug class, 2016 - 2027
6.3.6.1.2 Medications market size, by route of administration, 2016 - 2027
6.3.6.2 Market size, by distribution channel, 2016 - 2027
6.3.7 Italy
6.3.7.1 Market size, by treatment method, 2016 - 2027
6.3.7.1.1 Medications market size, by drug class, 2016 - 2027
6.3.7.1.2 Medications market size, by route of administration, 2016 - 2027
6.3.7.2 Market size, by distribution channel, 2016 - 2027
6.3.8 Spain
6.3.8.1 Market size, by treatment method, 2016 - 2027
6.3.8.1.1 Medications market size, by drug class, 2016 - 2027
6.3.8.1.2 Medications market size, by route of administration, 2016 - 2027
6.3.8.2 Market size, by distribution channel, 2016 - 2027
6.4 Latin America
6.4.1 Market size, by country, 2016 - 2027
6.4.2 Market size, by treatment method, 2016 - 2027
6.4.2.1 Medications market size, by drug class, 2016 - 2027
6.4.2.2 Medications market size, by route of administration, 2016 - 2027
6.4.3 Market size, by distribution channel, 2016 - 2027
6.4.4 Brazil
6.4.4.1 Market size, by treatment method, 2016 - 2027
6.4.4.1.1 Medications market size, by drug class, 2016 - 2027
6.4.4.1.2 Medications market size, by route of administration, 2016 - 2027
6.4.4.2 Market size, by distribution channel, 2016 - 2027
6.4.5 Mexico
6.4.5.1 Market size, by treatment method, 2016 - 2027
6.4.5.1.1 Medications market size, by drug class, 2016 - 2027
6.4.5.1.2 Medications market size, by route of administration, 2016 - 2027
6.4.5.2 Market size, by distribution channel, 2016 - 2027
6.5 Rest of the world
6.5.1 Market size, by country, 2016 - 2027
6.5.2 Market size, by treatment method, 2016 - 2027
6.5.2.1 Medications market size, by drug class, 2016 - 2027
6.5.2.2 Medications market size, by route of administration, 2016 - 2027
6.5.3 Market size, by distribution channel, 2016 - 2027
6.5.4 Australia
6.5.4.1 Market size, by treatment method, 2016 - 2027
6.5.4.1.1 Medications market size, by drug class, 2016 - 2027
6.5.4.1.2 Medications market size, by route of administration, 2016 - 2027
6.5.4.2 Market size, by distribution channel, 2016 - 2027
6.5.5 South Africa
6.5.5.1 Market size, by treatment method, 2016 - 2027
6.5.5.1.1 Medications market size, by drug class, 2016 - 2027
6.5.5.1.2 Medications market size, by route of administration, 2016 - 2027
6.5.5.2 Market size, by distribution channel, 2016 - 2027
Chapter 7 Company Profiles
7.1 Strategy dashboard, 2020
7.2 Vertex Pharmaceuticals Incorporated
7.2.1 Business overview
7.2.2 Financial data
7.2.3 Product landscape
7.2.4 Strategic outlook
7.2.5 SWOT analysis
7.3 Roche
7.3.1 Business overview
7.3.2 Financial data
7.3.3 Product landscape
7.3.4 Strategic outlook
7.3.5 SWOT analysis
7.4 Nestle Health Science
7.4.1 Business overview
7.4.2 Financial data
7.4.3 Product landscape
7.4.4 Strategic outlook
7.4.5 SWOT analysis
7.5 Abbvie
7.5.1 Business overview
7.5.2 Financial data
7.5.3 Product landscape
7.5.4 Strategic outlook
7.5.5 SWOT analysis
7.6 Viatris Inc
7.6.1 Business overview
7.6.2 Financial data
7.6.3 Product landscape
7.6.4 Strategic outlook
7.6.5 SWOT analysis
7.7 Horizon Therapeutics plc
7.7.1 Business overview
7.7.2 Financial data
7.7.3 Product landscape
7.7.4 Strategic outlook
7.7.5 SWOT analysis
7.8 Gilead
7.8.1 Business overview
7.8.2 Financial data
7.8.3 Product landscape
7.8.4 Strategic outlook
7.8.5 SWOT analysis
7.9 Chiesi Farmaceutici
7.9.1 Business overview
7.9.2 Financial data
7.9.3 Product landscape
7.9.4 Strategic outlook
7.9.5 SWOT analysis
7.10 Pharmaxis Ltd
7.10.1 Business overview
7.10.2 Financial data
7.10.3 Product landscape
7.10.4 Strategic outlook
7.10.5 SWOT analysis
7.11 Teva Pharmaceuticals
7.11.1 Business overview
7.11.2 Financial data
7.11.3 Product landscape
7.11.4 Strategic outlook
7.11.5 SWOT analysis



List of Tables

Data Tables
TABLE 1 Cystic fibrosis therapeutics industry 360 degree synopsis, 2016 - 2027
TABLE 2 Cystic fibrosis therapeutics market, 2016-2027 (USD Million)
TABLE 3 Cystic fibrosis therapeutics market, by treatment method, 2016-2027 (USD Million)
TABLE 4 Cystic fibrosis medications market, by drug class, 2016-2027 (USD Million)
TABLE 5 Cystic fibrosis medications market, by route of administration, 2016-2027 (USD Million)
TABLE 6 Cystic fibrosis therapeutics market, by distribution channel, 2016-2027 (USD Million)
TABLE 7 Cystic fibrosis therapeutics market, by region, 2016-2027 (USD Million)
TABLE 8 Industry impact forces
TABLE 9 Medications market size, by region, 2016-2027 (USD Million)
TABLE 10 CFTR modulators market size, by region, 2016-2027 (USD Million)
TABLE 11 Mucolytics market size, by region, 2016-2027 (USD Million)
TABLE 12 Bronchodilators market size, by region, 2016-2027 (USD Million)
TABLE 13 Pancreatic enzyme supplements market size, by region, 2016-2027 (USD Million)
TABLE 14 Others market size, by region, 2016-2027 (USD Million)
TABLE 15 Oral Drugs market size, by region, 2016-2027 (USD Million)
TABLE 16 Inhaled Drugs market size, by region, 2016-2027 (USD Million)
TABLE 17 Devices market size, by region, 2016-2027 (USD Million)
TABLE 18 Others market size, by region, 2016-2027 (USD Million)
TABLE 19 Hospitals market size, by region, 2016-2027 (USD Million)
TABLE 20 Retail pharmacies market size, by region, 2016-2027 (USD Million)
TABLE 21 Other market size, by region, 2016-2027 (USD Million)
TABLE 22 North America cystic fibrosis therapeutics market size, by country, 2016-2027 (USD Million)
TABLE 23 North America cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)
TABLE 24 North America cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)
TABLE 25 North America cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)
TABLE 26 North America cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)
TABLE 27 U.S. Cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)
TABLE 28 U.S. cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)
TABLE 29 U.S. cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)
TABLE 30 U.S. Cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)
TABLE 31 Canada Cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)
TABLE 32 Canada cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)
TABLE 33 Canada cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)
TABLE 34 Canada Cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)
TABLE 35 Europe Cystic fibrosis therapeutics market size, by country, 2016-2027 (USD Million)
TABLE 36 Europe Cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)
TABLE 37 Europe cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)
TABLE 38 Europe cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)
TABLE 39 Europe Cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)
TABLE 40 Germany Cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)
TABLE 41 Germany cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)
TABLE 42 Germany cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)
TABLE 43 Germany Cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)
TABLE 44 France Cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)
TABLE 45 France cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)
TABLE 46 France cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)
TABLE 47 France Cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)
TABLE 48 UK Cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)
TABLE 49 UK cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)
TABLE 50 UK cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)
TABLE 51 UK Cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)
TABLE 52 Italy Cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)
TABLE 53 Italy cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)
TABLE 54 Italy cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)
TABLE 55 Italy cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)
TABLE 56 Spain cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)
TABLE 57 Spain cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)
TABLE 58 Spain cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)
TABLE 59 Spain cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)
TABLE 60 Latin America Cystic fibrosis therapeutics market size, by country, 2016-2027 (USD Million)
TABLE 61 Latin America Cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)
TABLE 62 Latin America cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)
TABLE 63 Latin America cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)
TABLE 64 Latin America Cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)
TABLE 65 Brazil Cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)
TABLE 66 Brazil cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)
TABLE 67 Brazil cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)
TABLE 68 Brazil Cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)
TABLE 69 Mexico Cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)
TABLE 70 Mexico cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)
TABLE 71 Mexico cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)
TABLE 72 Mexico Cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)
TABLE 73 RoW cystic fibrosis therapeutics market size, by country, 2016-2027 (USD Million)
TABLE 74 RoW cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)
TABLE 75 RoW cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)
TABLE 76 RoW cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)
TABLE 77 RoW cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)
TABLE 78 Australia cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)
TABLE 79 Australia cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)
TABLE 80 Australia cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)
TABLE 81 Australia cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)
TABLE 82 South Africa cystic fibrosis therapeutics market size, by treatment method, 2016-2027 (USD Million)
TABLE 83 South Africa cystic fibrosis medications market size, by drug class, 2016-2027 (USD Million)
TABLE 84 South Africa cystic fibrosis medications market size, by route of administration, 2016-2027 (USD Million)
TABLE 85 South Africa cystic fibrosis therapeutics market size, by distribution channel, 2016-2027 (USD Million)

Charts & Figures
FIG. 1 Industry segmentation
FIG. 2 Global cystic fibrosis therapeutics market size, 2016 - 2027 (USD Million)
FIG. 3 Growth potential analysis, by treatment method
FIG. 4 Growth potential analysis, by distribution channel
FIG. 5 Porter’s analysis
FIG. 6 Competitive matrix analysis, 2020
FIG. 7 PESTEL analysis
FIG. 8 Key segment trends, by treatment method
FIG. 9 Key segment trends, by distribution channel
FIG. 10 Key regional trends, by region
FIG. 11 Strategy dashboard, 2020